Literature DB >> 23061697

Rules for identifying potentially reactive or promiscuous compounds.

Robert F Bruns1, Ian A Watson.   

Abstract

This article describes a set of 275 rules, developed over an 18-year period, used to identify compounds that may interfere with biological assays, allowing their removal from screening sets. Reasons for rejection include reactivity (e.g., acyl halides), interference with assay measurements (fluorescence, absorbance, quenching), activities that damage proteins (oxidizers, detergents), instability (e.g., latent aldehydes), and lack of druggability (e.g., compounds lacking both oxygen and nitrogen). The structural queries were profiled for frequency of occurrence in druglike and nondruglike compound sets and were extensively reviewed by a panel of experienced medicinal chemists. As a means of profiling the rules and as a filter in its own right, an index of biological promiscuity was developed. The 584 gene targets with screening data at Lilly were assigned to 17 subfamilies, and the number of subfamilies at which a compound was active was used as a promiscuity index. For certain compounds, promiscuous activity disappeared after sample repurification, indicating interference from occult contaminants. Because this type of interference is not amenable to substructure search, a "nuisance list" was developed to flag interfering compounds that passed the substructure rules.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061697     DOI: 10.1021/jm301008n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  82 in total

1.  Thermodynamic Proxies to Compensate for Biases in Drug Discovery Methods.

Authors:  Sean Ekins; Nadia K Litterman; Christopher A Lipinski; Barry A Bunin
Journal:  Pharm Res       Date:  2015-08-27       Impact factor: 4.200

2.  Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.

Authors:  Richard S Judson; Felicia Maria Magpantay; Vijay Chickarmane; Cymra Haskell; Nessy Tania; Jean Taylor; Menghang Xia; Ruili Huang; Daniel M Rotroff; Dayne L Filer; Keith A Houck; Matthew T Martin; Nisha Sipes; Ann M Richard; Kamel Mansouri; R Woodrow Setzer; Thomas B Knudsen; Kevin M Crofton; Russell S Thomas
Journal:  Toxicol Sci       Date:  2015-08-13       Impact factor: 4.849

Review 3.  Open source molecular modeling.

Authors:  Somayeh Pirhadi; Jocelyn Sunseri; David Ryan Koes
Journal:  J Mol Graph Model       Date:  2016-07-30       Impact factor: 2.518

4.  Idea2Data: Toward a New Paradigm for Drug Discovery.

Authors:  Christos A Nicolaou; Christine Humblet; Hong Hu; Eva M Martin; Frank C Dorsey; Thomas M Castle; Keith Ian Burton; Haitao Hu; Jorg Hendle; Michael J Hickey; Joel Duerksen; Jibo Wang; Jon A Erickson
Journal:  ACS Med Chem Lett       Date:  2019-02-04       Impact factor: 4.345

5.  Structure-Promiscuity Relationship Puzzles-Extensively Assayed Analogs with Large Differences in Target Annotations.

Authors:  Ye Hu; Swarit Jasial; Erik Gilberg; Jürgen Bajorath
Journal:  AAPS J       Date:  2017-03-06       Impact factor: 4.009

6.  Computer-aided drug discovery research at a global contract research organization.

Authors:  Douglas B Kitchen
Journal:  J Comput Aided Mol Des       Date:  2016-11-01       Impact factor: 3.686

Review 7.  Challenges in working towards an internal threshold of toxicological concern (iTTC) for use in the safety assessment of cosmetics: Discussions from the Cosmetics Europe iTTC Working Group workshop.

Authors:  Corie A Ellison; Karen L Blackburn; Paul L Carmichael; Harvey J Clewell; Mark T D Cronin; Bertrand Desprez; Sylvia E Escher; Steve S Ferguson; Sébastien Grégoire; Nicola J Hewitt; Heli M Hollnagel; Martina Klaric; Atish Patel; Sabrina Salhi; Andreas Schepky; Barbara G Schmitt; John F Wambaugh; Andrew Worth
Journal:  Regul Toxicol Pharmacol       Date:  2019-01-15       Impact factor: 3.271

8.  Workflow for defining reference chemicals for assessing performance of in vitro assays.

Authors:  Richard S Judson; Russell S Thomas; Nancy Baker; Anita Simha; Xia Meng Howey; Carmen Marable; Nicole C Kleinstreuer; Keith A Houck
Journal:  ALTEX       Date:  2018-12-17       Impact factor: 6.043

9.  Evaluation of androgen assay results using a curated Hershberger database.

Authors:  N C Kleinstreuer; P Browne; X Chang; R Judson; W Casey; P Ceger; C Deisenroth; N Baker; K Markey; R S Thomas
Journal:  Reprod Toxicol       Date:  2018-09-08       Impact factor: 3.143

10.  Miro1 Marks Parkinson's Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson's Models.

Authors:  Chung-Han Hsieh; Li Li; Roeland Vanhauwaert; Kong T Nguyen; Mary D Davis; Guojun Bu; Zbigniew K Wszolek; Xinnan Wang
Journal:  Cell Metab       Date:  2019-09-26       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.